Stay updated on Subcutaneous Lirentelimab in Urticaria: Clinical Trial

Sign up to get notified when there's something new on the Subcutaneous Lirentelimab in Urticaria: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Subcutaneous Lirentelimab in Urticaria: Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    Revision: v3.3.2 was added to the study documents, replacing the previous Revision: v3.2.0.
    Difference
    0.0%
    Check dated 2025-11-24T20:53:17.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The government funding/operating status banner was removed from the page. The page now presents only the study details and related information.
    Difference
    0.2%
    Check dated 2025-11-17T18:11:18.000Z thumbnail image
  4. Check
    34 days ago
    Change Detected
    Summary
    No additions or deletions were detected; the study details page remains consistent across views. The page continues to present trial information, locations, eligibility criteria, and outcomes.
    Difference
    0.3%
    Check dated 2025-11-03T12:48:50.000Z thumbnail image
  5. Check
    63 days ago
    Change Detected
    Summary
    Key updates: version bump to v3.2.0 and the new government-operating-status notice; the previous v3.1.0 reference was removed. Overall, user-facing status and versioning information were updated. If there are no other changes, this is the main shift.
    Difference
    3%
    Check dated 2025-10-05T17:42:12.000Z thumbnail image
  6. Check
    70 days ago
    Change Detected
    Summary
    Updated to Revision v3.1.0 and removal of multiple drug-safety topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs), indicating content pruning in the drug-safety area and a new version tag.
    Difference
    0.3%
    Check dated 2025-09-28T11:17:05.000Z thumbnail image
  7. Check
    84 days ago
    Change Detected
    Summary
    - Updated revision to v3.0.2 and removed the Back to Top element. - There are no significant changes to core content or critical information such as pricing, stock, or time slots.
    Difference
    0.2%
    Check dated 2025-09-14T00:51:07.000Z thumbnail image

Stay in the know with updates to Subcutaneous Lirentelimab in Urticaria: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Subcutaneous Lirentelimab in Urticaria: Clinical Trial page.